| | | | |
p value
|
|---|
|
Characteristics
|
Healthy controls
|
A
|
B
|
Control vs. A
|
Control vs. B
|
A vs. B
|
|---|
|
Number of patients
|
62
|
62
|
62
| | | |
|
Age, years
|
9.1 ± 4.3
|
9.6 ± 3.6
|
9.6 ± 3.6
| | | |
|
Male/female ratio
|
30/32
|
30/32
|
30/32
| | | |
|
WBC (count/mm3)a
|
7800 (4800–11,000)
|
5440 (2100–27,400)
|
7197 (3900–6200)
|
0.023
|
0.021
|
NS
|
|
Platelet counts (count × 103/mm3)a
|
336 (176–967)
|
278 (22–748)
|
298 (69–554)
|
NS
|
NS
|
0.042
|
|
MPV (fL)
|
8.28 ± 1.13
|
9.47 ± 1.62
|
8.84 ± 1.48
|
<0.0001
|
<0.0001
|
0.005
|
|
AST (IU/L)a
|
27(11–33)
|
927 (34–4145)
|
33 (16–519)
|
<0.0001
|
0.004
|
<0.0001
|
|
ALT (IU/L)a
|
14 (6–36)
|
1250 (36–4113)
|
35 (6–1358)
|
<0.0001
|
<0.0001
|
<0.0001
|
|
T. bil (IU/L)a
|
–
|
1 (0.3–17.2)
| | | | |
|
D. bil(IU/L)a
|
–
|
0.67 (0.1–7.7)
| | | | |
|
PTT
|
–
|
29.1 (18.1–46.9)
| | | | |
|
PT
|
–
|
13.7 (10.7–35.1)
| | | | |
- Parametric values were expressed as means with standard deviation. Significance was determined by p < 0.05
-
AST aspartate transaminase, ALT alanine transaminase, PT prothrombin time, aPTT activated partial thromboplastin time, MPV mean platelet volume, WBC white blood cell, T.bil total bilirubin, D.bil direct bilirubin, NS not significant
-
aIf not normally distributed, values were presented as median (minimum-maximum)
